13 hrs ago
Xenia Daily Gazette
Lying to the sick
The Affordable Care Act gets more and more curious. President Barack Obama promised to protect those with preexisting conditions and help the uninsured.
Tue Dec 10, 2013
Chapel Hill News
UNC starts support group for fathers widowed by cancer
Dan Pelletier remembers some tense conversations in the JC Penney's junior department when he and his pre-teen daughter first shopped together for her clothes.
"Ovarian Cancer Global Clinical Trials Review, H2, 2013" Published
GlobalData's clinical trial report, "Ovarian Cancer Global Clinical Trials Review, H2, 2013" provides data on the Ovarian Cancer clinical trial scenario.
Mon Dec 09, 2013
FoundationOnea Heme Enables Identification of Genomic Alterations...
Foundation Medicine today announced new data demonstrating that its fully informative genomic profile for hematologic cancers, FoundationOne Heme, can be performed in routine clinical cancer specimens to identify all classes of genomic alterations, including gene fusions, across hundreds of genes related to oncogenesis in patients with hematologic ... (more)
Wall Street Journal
The Next Front in Cancer Care
For cancer patients, getting through the rigors of treatment is the first hurdle.
Financial Times' Kirchgaessner: Obamacare Won't Include Top Hospitals
Some Americans won't have access to a number of the nation's top hospitals under the Affordable Care Act, according to Stephanie Kirchgaessner, Washington correspondent for The Financial Times.
Bio IT World
The New Cancer Models, Part 3: The Cell Line Critics
We know that cancer is a personal disease, with each case displaying a unique genetic makeup that demands uniquely targeted therapy.
Hopes raised for simplification of cancer research
Cancer biologist Joan MassaguA© was appointed as head of the research arm of the Memorial Sloan-Kettering Cancer Center in New York last month.
Encouraging Clinical Data From Multicenter Phase 1/2 Trial On...
Actinium Pharmaceuticals, Inc. , a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, were presented in a poster session on Saturday, December 7, 2013 at the American Society of Hematology's 55th Annual Meeting and Exposition in New Orleans.
Chemical and Engineering News
Juno Makes A Grand Entrance
Juno Therapeutics , a Seattle-based company focused on cancer immunotherapy, has debuted with a whopping $120 million in financing, one of the biggest-ever initial funding rounds for a biotech firm.
Sun Dec 08, 2013
Battle of the Sexes: "Brotox"
Dr. Rossi is a research investigator at the Memorial Sloan-Kettering Cancer Center and in private practice, both in New York, New York.
Sat Dec 07, 2013
The Morning Call
Penn researchers report success in leukemia treatment
Three years ago, University of Pennsylvania researchers wondered whether their early success with a novel immune therapy was the dawn of a revolution in cancer treatment, or a fluke.
Looking Forward: Juv derm Voluma for Midface Volume
Dr. Rossi is a research investigator at the Memorial Sloan-Kettering Cancer Center and is in private practice, both in New York, New York.
Foundation Medicine Launches FoundationOnea Heme, Developed in...
FoundationOne Heme, Foundation Medicine's Second Clinical Product, is a Fully Informative Genomic Profile for Hematologic Malignancies, Sarcomas and Pediatric Cancers )-- Foundation Medicine announced today the launch of its second clinical product, FoundationOnea Heme, a fully informative genomic profile for hematologic cancers , as well as many ... (more)
Fri Dec 06, 2013
GSK Launches Global Consortium
GlaxoSmithKline plc [LSE/NYSE: GSK] announced today the formation of the Oncology Clinical and Translational Consortium , a collaborative scientific research network comprised of six internationally renowned comprehensive cancer centres.
James Blake Serves for a Cure to Raise Money for Memorial Sloan-Kettering Cancer Center
NEW YORK CITY - The James Blake Foundation brought tennis to New York's 69th Regiment Armory Thursday night for the 2013 edition of Serving for a Cure.
Skylight Healthcare Systems Selected as a Fierce Innovation Awards...
Skylight Healthcare Systems was recognized as a finalist in the category of Population Health Management.
Thu Dec 05, 2013
University of Massachusetts Dartmouth
Two UMass Dartmouth Biology Faculty Have Papers Published in National Scientific Journal
UMass Dartmouth Biology Assistant Professors Kathryn Kavanagh and Vanni Bucci both had papers published in the high impact scientific journal, "The Proceedings of the National Academy of Science" .
Wed Dec 04, 2013
Accomplished Scientist and Entrepreneur Selected to Lead...
NEW YORK, December 5, 2013 - Michael A. Foley, PhD, has been selected to lead the Tri-Institutional Therapeutics Discovery Institute, Inc. , a pioneering collaboration of Weill Cornell Medical College, The Rockefeller University and Memorial Sloan-Kettering Cancer Center that is designed to expedite early-stage drug discovery into novel treatments ... (more)
Indianapolis Business News
Lilly invests in NY life sciences venture capital initiative
Indianapolis-based Eli Lilly and Co. has joined two other companies to contribute $40 million to an early-stage life sciences venture capital initiative in New York City.